Article info
Original articles
Efficacy and tolerability of zolmitriptan oro-dispersible wafer in treatment of childhood migraine
- Correspondence to Dr Daniel B Hawcutt, University of Liverpool, Alder Hey Children's Hospital, Eaton Road, Liverpool L12 2AP, UK; D.Hawcutt{at}liv.ac.uk
Citation
Efficacy and tolerability of zolmitriptan oro-dispersible wafer in treatment of childhood migraine
Publication history
- Received June 4, 2013
- Revised September 11, 2013
- Accepted September 24, 2013
- First published October 18, 2013.
Online issue publication
July 20, 2016
Article Versions
- Previous version (20 July 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions